VEXAS综合征:临床与血液学特征及诊断和管理的实用方法
VEXAS综合征由UBA1体细胞突变引起,表现为难治性炎症状态伴血液学异常。外周血大细胞增多、单核细胞减少和/或血小板减少伴骨髓红系或髓系前体空泡化应引起怀疑。治疗选择有限,细胞因子靶向治疗如白介素-6抑制剂和JAK-STAT抑制剂以及低甲基化药物如阿扎胞苷显示部分效果,异基因干细胞移植可能持久缓解和潜在治愈。
要点
- 外周血大细胞增多、单核细胞减少和/或血小板减少伴骨髓空泡化应怀疑VEXAS综合征。
- UBA1基因检测是确诊依据,但可及性尚不普遍。
- 治疗缺乏前瞻性临床试验,白介素-6抑制剂、JAK-STAT抑制剂和阿扎胞苷显示部分效果。
核心结论
- VEXAS综合征由UBA1体细胞突变引起,表现为难治性炎症状态伴血液学异常,需及时识别和准确诊断以降低死亡率。
研究设计与样本
- 本文为综述,旨在概述VEXAS综合征的病理生理学并提供诊断和治疗的实用方法。
主要发现
- 患者可有广泛的临床症状,血液学参数通常非特异性,但外周血大细胞增多、单核细胞减少和/或血小板减少 coupled with 骨髓红系或髓系前体空泡化应引起怀疑。
- 由于死亡率增加,及时识别和准确诊断至关重要。
- UBA1变异检测尚未普遍可及,临床医生应了解当前可用的遗传确认选项。
- 治疗选择有限,缺乏前瞻性临床试验,但细胞因子靶向治疗如白介素-6抑制剂和JAK-STAT抑制剂以及低甲基化药物如阿扎胞苷已显示部分效果证据。
- 尽管病例有限,异基因干细胞移植有望实现持久缓解和潜在治愈。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a newly identified disease caused by somatic alterations in UBA1 which produce a recalcitrant inflammatory state along with hematologic disturbances. Patients with VEXAS can have a wide spectrum of clinical symptoms and providers should be familiar with the heterogeneity of associated clinical features. While hematologic parameters may be generally non-specific, peripheral blood features of macrocytosis, monocytopenia, and/or thrombocytopenia coupled with bone marrow vacuolization of erythroid or myeloid precursors should raise suspicion for this condition. Due to an increased mortality, prompt recognition and accurate diagnosis is paramount. Access to testing for confirmation of UBA1 variants is not yet universally available but clinicians should understand the current available options for genetic confirmation of this disease. Treatment options are limited due to lack of prospective clinical trials but cytokine directed therapies such as interleukin-6 inhibitors and JAK-STAT inhibitors as well as hypomethylating agents such as azacitidine have shown evidence of partial effect. Though cases are limited, allogeneic stem cell transplantation holds promise for durable response and potential cure. The intent of this review is to outline the pathophysiology of VEXAS syndrome and to provide a practical approach to diagnosis and treatment.
引用
- Koster MJ, Lasho TL, Olteanu H, et al. VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management. Am J Hematol. 2023. PMID: 37950858. doi:10.1002/ajh.27156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。